Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             31 results found
no title author magazine year volume issue page(s) type
1 A perspective on risks that impede development of drugs to modify the course of Alzheimer’s disease: Can they be reduced? Mohs, Richard C.
2008
4 1S1 p. S85-S87
3 p.
article
2 Apolipoprotein E represents a potent gene-based therapeutic target for the treatment of sporadic Alzheimer’s disease Poirier, Judes
2008
4 1S1 p. S91-S97
7 p.
article
3 A quarter century of advancing treatment for Alzheimer’s disease with Leon J. Thal Grundman, Michael
2008
4 1S1 p. S51-S55
5 p.
article
4 Challenges in clinical research on Alzheimer’s disease: Leon Thal’s legacy Petersen, Ronald C.
2008
4 1S1 p. S88-S90
3 p.
article
5 Chronic disease long-term drug prevention trials: Lessons from the Alzheimer’s Disease Anti-inflammatory Prevention Trial (ADAPT) Meinert, Curtis L.
2008
4 1S1 p. S7-S14
8 p.
article
6 Contents 2008
4 1S1 p. A3-
1 p.
article
7 Contents 2008
4 1S1 p. A4-
1 p.
article
8 Current and future management of Alzheimer’s disease Gauthier, Serge
2008
4 1S1 p. S48-S50
3 p.
article
9 Current challenges for the successful treatment and prevention of Alzheimer’s disease: Treating the pathologies of the disease to change its clinical course Schenk, Dale
2008
4 1S1 p. S119-S121
3 p.
article
10 Dementia: Is it time for a change in focus? Kuller, Lewis H.
2008
4 1S1 p. S77-S84
8 p.
article
11 Differentiating Alzheimer’s disease from dementia with Lewy bodies and Parkinson’s disease with (+)-[11C]dihydrotetrabenazine positron emission tomography Koeppe, Robert A.
2008
4 1S1 p. S67-S76
10 p.
article
12 Disease-modifying approaches to Alzheimer’s disease: Challenges and opportunities—Lessons from donepezil therapy Sabbagh, Marwan N.
2008
4 1S1 p. S109-S118
10 p.
article
13 Drug discovery and the prevention of Alzheimer’s disease Fillit, Howard
2008
4 1S1 p. S26-S28
3 p.
article
14 Editorial board 2008
4 1S1 p. A5-
1 p.
article
15 Electroencephalography and event-related potentials as biomarkers of mild cognitive impairment and mild Alzheimer’s disease Jackson, Colleen E.
2008
4 1S1 p. S137-S143
7 p.
article
16 Eyes on the prize: Federal Alzheimer’s research effort aims to facilitate interventions Hodes, Richard J.
2008
4 1S1 p. S37-S47
11 p.
article
17 Home-based technologies: A new paradigm for conducting dementia prevention trials Kaye, Jeffrey
2008
4 1S1 p. S60-S66
7 p.
article
18 Leon Joel Thal, MD, 1944–2007: Honoring his scientific legacy Khachaturian, Zaven S.
2008
4 1S1 p. S1-S3
3 p.
article
19 Leon Thal and the therapeutic age of Alzheimer’s disease Aisen, Paul S.
2008
4 1S1 p. S4-S6
3 p.
article
20 Leon Thal’s vision for the treatment and prevention of Alzheimer’s disease Weiner, Michael W.
2008
4 1S1 p. S150-S152
3 p.
article
21 Medical and scientific advisory council 2008
4 1S1 p. A6-
1 p.
article
22 Memory health clinics—a first step to prevention Vellas, Bruno
2008
4 1S1 p. S144-S149
6 p.
article
23 More than a decade of estrogen neuroprotection Simpkins, James W.
2008
4 1S1 p. S131-S136
6 p.
article
24 Optimizing phase II of drug development for disease-modifying compounds Cummings, Jeffrey L.
2008
4 1S1 p. S15-S20
6 p.
article
25 Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses Cansev, Mehmet
2008
4 1S1 p. S153-S168
16 p.
article
26 Prevention therapeutics of dementia Schneider, Lon S.
2008
4 1S1 p. S122-S130
9 p.
article
27 Realizing the potential of positron emission tomography with 18F-fluorodeoxyglucose to improve the treatment of Alzheimer’s disease Foster, Norman L.
2008
4 1S1 p. S29-S36
8 p.
article
28 Subscriber information page 2008
4 1S1 p. A2-
1 p.
article
29 The oldest old and the 90+ Study Kawas, Claudia H.
2008
4 1S1 p. S56-S59
4 p.
article
30 The pre–mild cognitive impairment, subjective cognitive impairment stage of Alzheimer’s disease Reisberg, Barry
2008
4 1S1 p. S98-S108
11 p.
article
31 We should not distinguish between symptomatic and disease-modifying treatments in Alzheimer’s disease drug development Doody, Rachelle S.
2008
4 1S1 p. S21-S25
5 p.
article
                             31 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands